 1. All patients aged 16-65 years were considered eligible acute promyelocytic leukemia excluded, including those with an antecedent diagnosis of myelodysplasiahematological disorder andor secondary AML. Both age and disease subtype selection criteria are broader than in most studies on adult AML, adhering more closely to the reported epidemiology of the disease. 